dbio NEWS
& MEDIA
  • Facebook - Black Circle
  • Twitter - Black Circle
  • YouTube - Black Circle

follow US

FOLLOW US

NEWS

RSS Feed
 

Op-Ed: An antibody therapy could get us to the new normal. By Jacob Glanville

Recent good news regarding COVID-19 vaccines comes with a catch. In late June, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, reminded the world that no vaccine is perfect and he would "settle" for a COVID-19 vaccine that is 70% to 75% effective. Furthermore, he cautioned that this incomplete protection, when coupled with the looming possibility that half of the public may choose not to receive this vaccine, would make it "unlikely" that the United States achieves sufficient levels of herd immunity to quell the pandemic. Dr. Fauci’s commentary reflects an increasingly acknowledged point about efforts to combat COVID-19: Although developing vaccines

PRESS

 

Distributed Bio in the news

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio's efforts to 

BUSINESS WIRE | Oct 25, 2018

Charles River and Distributed Bio Enter Exclusive Partnership to Create an Integrated Antibody Discovery and Development Platform

BUSINESS WIRE | Oct 25, 2018

Distributed Bio Announces SuperHuman Platform Transfer to Kadmon

BUSINESS WIRE | Feb. 28, 2018

Pfizer, Boehringer sign JLABS resident Distributed Bio’s antibody discovery platform

FIERECE BIOTECH | Jan. 11, 2018

Distributed Bio Announces SuperHuman Platform License Agreement With Pfizer Inc.

BUSINESS WIRE | Jan. 5 2018

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

BUSINESS WIRE | Dec. 12, 2017

Distributed Bio and Boehringer Ingelheim Announce SuperHuman Platform Transfer

BUSINESS WIRE | Dec. 11, 2017

VIDEOS

All videos are free to view & download

 

PUBLICATIONS

 

PRESENTATIONS

All presentations are free to view & download

 

SUPERHUMAN 2.0

CARTERRA

PROTEIN ENGINEERING

SUMMIT

IBC TALK 2017

PEGS 2012

THE BETTER BIOLOGIC

PEGS 2013

REPERTOIRE ANALYSIS

& BIOLOGICS OPTIMIZATIONS

NOVEL SEQUENCING TECHNIQUES & COMPUTATIONAL DISCOVERY

CHARACTERIZING HERITABLE VARIATION IN THE ANTIBODY REPERTOIRE

(415) 489-0246

201 Gateway Blvd, Floor 1

 South San Francisco, CA 94080, USA